FSMAX | IMORX | FSMAX / IMORX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 13 years | - |
Gain YTD | 3.994 | 3.945 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.8B | 738M | 5,528% |
Annual Yield % from dividends | 1.10 | 0.00 | - |
Returns for 1 year | 26.14 | 4.95 | 528% |
Returns for 3 years | 21.40 | 8.15 | 263% |
Returns for 5 years | 48.39 | -14.08 | -344% |
Returns for 10 years | 90.18 | -21.67 | -416% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QUARX | 61.49 | 0.57 | +0.94% |
AB Small Cap Growth R | |||
CNRUX | 24.93 | 0.23 | +0.93% |
City National Rochdale US Cor Eq Instl | |||
VEMRX | 92.22 | 0.58 | +0.63% |
Vanguard Emerging Mkts Stock Idx InsPlus | |||
WFDSX | 32.32 | 0.03 | +0.09% |
Allspring SMID Cap Growth Fund - Cl Inst | |||
SPEGX | 18.36 | N/A | N/A |
Alger Responsible Investing A |